FDA to discuss diabetes outcomes

FDA's Center for Drug Evaluation and Research will hold a public workshop on Aug. 29 titled "Diabetes Outcome Measures Beyond Hemoglobin A1c (HbA1c)." FDA said the meeting will aim to address how well...